Ovarian cancer and BRCA mutation genetic testing: the Brazilian reality
Introduction: Ovarian cancer (OC) is one of the leading causes of women’s cancer deaths worldwide. Recent clinical trials with PARP inhibitors showed promising therapeutic opportunities for OC patients. The assessment of BRCA mutation is well established as relevant in the prevention, early diagnost...
Main Authors: | Dalila Cunha de Oliveira, Luciana Lopes Mensor, Aniere Lima Banho, Guareide Carelli, Amanda Lins Acerbi, Andrea Paiva Gadelha Guimaraes, Angelica Nogueira-Rodrigues |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2021-10-01
|
Series: | Brazilian Journal of Oncology |
Subjects: | |
Online Access: | http://www.brazilianjournalofoncology.com.br/details/171/en-US/ovarian-cancer-and-brca-mutation-genetic-testing--the-brazilian-reality |
Similar Items
-
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision
by: Kelsey E. Lewis, et al.
Published: (2018-02-01) -
Impact of the COVID-19 pandemic on ovarian tissue cryopreservation planning in the Bologna clinical center
by: Valentina Magnani, et al.
Published: (2022-12-01) -
The BRCA Gene in Epithelial Ovarian Cancer
by: Luisa Sánchez-Lorenzo, et al.
Published: (2022-02-01) -
Clinical case of ovarian cancer during pregnancy
by: Y E Dobrokhotova, et al.
Published: (2016-04-01) -
BRCA1 mutations in Brazilian patients
by: Juliano Javert Lourenço, et al.
Published: (2004-01-01)